Pabinger Ingrid or Pabinger-Faching Ingrid

Pabinger Ingrid or Pabinger-Faching Ingrid

Medizinische Universität Wien

H-index: 96

Europe-Austria

About Pabinger Ingrid or Pabinger-Faching Ingrid

Pabinger Ingrid or Pabinger-Faching Ingrid, With an exceptional h-index of 96 and a recent h-index of 56 (since 2020), a distinguished researcher at Medizinische Universität Wien, specializes in the field of Thrombosis and Haemostasis.

His recent articles reflect a diverse array of research interests and contributions to the field:

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Platelet function analyzer (PFA-100) in patients with bleeding disorder of unknown cause

Rates of Venous Thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital Hemophilia A or B: a systematic review

High risk of thromboembolic events in adult with primary immune thrombocytopenia: results from a prospective cohort study

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion

Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer

A Unique Clinical Case of Using Emicizumab as an Effective Therapeutic Approach for Refractory Acquired Hemophilia

Pabinger Ingrid or Pabinger-Faching Ingrid Information

University

Medizinische Universität Wien

Position

Division of Haematology and Haemostaseology

Citations(all)

35864

Citations(since 2020)

13704

Cited By

27670

hIndex(all)

96

hIndex(since 2020)

56

i10Index(all)

400

i10Index(since 2020)

251

Email

University Profile Page

Medizinische Universität Wien

Pabinger Ingrid or Pabinger-Faching Ingrid Skills & Research Interests

Thrombosis and Haemostasis

Top articles of Pabinger Ingrid or Pabinger-Faching Ingrid

Title

Journal

Author(s)

Publication Date

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Thrombosis Research

Dino Mehic

Theresa Schramm

Birgit Forstner-Bergauer

Helmuth Haslacher

Cihan Ay

...

2024/3/1

Platelet function analyzer (PFA-100) in patients with bleeding disorder of unknown cause

Hämostaseologie

D Mehic

B Eichinger

T Dreier

J Rast

A Tolios

...

2024/2

Rates of Venous Thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital Hemophilia A or B: a systematic review

Davide Santagata

Alessia Abenante

Alessandro Squizzato

Francesco Dentali

Marco Paolo Donadini

...

2024/1/11

High risk of thromboembolic events in adult with primary immune thrombocytopenia: results from a prospective cohort study

Hämostaseologie

J Rast

T Schramm

D Mehic

M Fillitz

B Dixer

...

2024/2

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Hämostaseologie

C Englisch

F Moik

D Steiner

A Berghoff

M Preusser

...

2024/2

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion

Dino Mehic

Johanna Gebhart

Ingrid Pabinger

2024/2/27

Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer

Thrombosis Research

Tomohiro Kawano

Cornelia Englisch

Yohei Hisada

David Paul

Sierra Archibald

...

2024/5/1

A Unique Clinical Case of Using Emicizumab as an Effective Therapeutic Approach for Refractory Acquired Hemophilia

Hämostaseologie

L Hambardzumyan

I Pabinger

G Tamamyan

S Danelyan

S Araqelyan

...

2024/2

Age-related differences in the presentation, management, and clinical outcomes of 100,000 patients with venous thromboembolism in the RIETE registry

Archivos de Bronconeumología

Alberto García Ortega

David Jiménez

Ana Pedro-Tudela

Cristina Pérez-Ductor

Carmen Fernández-Capitán

...

2024/1/3

Platelet glycoprotein IIb-and IIIa levels are altered in persistently lupus anticoagulant positive patients with a history of thrombosis

Hämostaseologie

F Hsu

T Schramm

A Sedighi

W Schrottmaier

C Ay

...

2024/2

Expert consensus on an algorithm for rapid exclusion of clinically relevant plasma levels of direct oral anticoagulants in patients using the DOAC Dipstick

Hämostaseologie

J Harenberg

R Gosselin

I Pabinger

C Becattini

A Cuker

...

2024/2

Multicenter assessment and longitudinal study of the prevalence of antibodies and related adaptive immune responses to AAV in adult males with hemophilia

Gene Therapy

Ingrid Pabinger

Mila Ayash-Rashkovsky

Miguel Escobar

Barbara A Konkle

María Eva Mingot-Castellano

...

2024/2/14

First diagnosed inherited TTP combined with inherited thrombophilia in a pregnant woman

Hämostaseologie

O Kostenchak-Svystak

I Pabinger

O Puzii

2024/2

The plasma miRNome and venous thromboembolism in high‐grade glioma: miRNA Sequencing of a nested case–control cohort

Journal of Cellular and Molecular Medicine

Friedrich Erhart

Georg Widhalm

Barbara Kiesel

Matthias Hackl

Andreas Diendorfer

...

2024/4

Impact of thrombosis location on walking capacity: a cohort study of patients with acute deep vein thrombosis

Research and Practice in Thrombosis and Haemostasis

Daniel Steiner

Stephan Nopp

Ingrid Pabinger

Eva Dassler

Renate Koppensteiner

...

2024/1/1

Transfer RNAs, not microRNAs, are linked to ischemic stroke and major bleeding in patients with end-stage kidney disease–a nested case-control study from the VIVALDI cohort

Hämostaseologie

S Nopp

O Königsbrügge

M Säemann

I Pabinger

AY Nossent

...

2024/2

Telomere length is associated with increased risk of bleeding in patients on hemodialysis

Hämostaseologie

R Vostatek

P Hohensinner

S Schmaldienst

M Lorenz

R Klauser-Braun

...

2024/2

Clinical presentation and outcomes of patients with cancer-associated isolated distal deep vein thrombosis

Journal of Clinical Oncology

Jean-Philippe Galanaud

Javier Trujillo-Santos

Behnood Bikdeli

Laurent Bertoletti

Pierpaolo Di Micco

...

2024/2/10

Association of telomere length, a marker of biological aging, with hemophilia severity

Hämostaseologie

M Trappl

R Vostatek

D Kraemmer

P Hohensinner

I Pabinger

...

2024/2

Standardisation of Definition and Management for Bleeding Disorder of Unknown Cause: Communication from the SSC of the ISTH.

Journal of thrombosis and haemostasis

Ross I Baker

Philip Choi

Nicola Curry

Johanna Gebhart

Keith Gomez

...

2024/3/20

See List of Professors in Pabinger Ingrid or Pabinger-Faching Ingrid University(Medizinische Universität Wien)

Pabinger Ingrid or Pabinger-Faching Ingrid FAQs

What is Pabinger Ingrid or Pabinger-Faching Ingrid's h-index at Medizinische Universität Wien?

The h-index of Pabinger Ingrid or Pabinger-Faching Ingrid has been 56 since 2020 and 96 in total.

What are Pabinger Ingrid or Pabinger-Faching Ingrid's top articles?

The articles with the titles of

Activated protein C and free protein S in patients with mild to moderate bleeding disorders

Platelet function analyzer (PFA-100) in patients with bleeding disorder of unknown cause

Rates of Venous Thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital Hemophilia A or B: a systematic review

High risk of thromboembolic events in adult with primary immune thrombocytopenia: results from a prospective cohort study

Incidence and outcomes of bleeding events in patients with cancer: results from a prospective cohort study

Bleeding Disorder of Unknown Cause: A Diagnosis of Exclusion

Mucin 1 and venous thrombosis in tumor-bearing mice and patients with cancer

A Unique Clinical Case of Using Emicizumab as an Effective Therapeutic Approach for Refractory Acquired Hemophilia

...

are the top articles of Pabinger Ingrid or Pabinger-Faching Ingrid at Medizinische Universität Wien.

What are Pabinger Ingrid or Pabinger-Faching Ingrid's research interests?

The research interests of Pabinger Ingrid or Pabinger-Faching Ingrid are: Thrombosis and Haemostasis

What is Pabinger Ingrid or Pabinger-Faching Ingrid's total number of citations?

Pabinger Ingrid or Pabinger-Faching Ingrid has 35,864 citations in total.